Tuesday, June 7, 2016

Judge Sides With Gilead Against Merck in Hepatitis C Case

A federal judge reversed a jury verdict that Gilead Sciences should pay $200 million to Merck & Co. in a patent dispute over hepatitis C drugs.

from WSJ.com: US Business http://ift.tt/1TXRe4v
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)